KR950703345A - 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체가 주성분인 조성물 및 그것을 함유하는 컨테이너(composition based on polyoxyethylene-polyoxypropylene block copolymers and container contaning it) - Google Patents

폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체가 주성분인 조성물 및 그것을 함유하는 컨테이너(composition based on polyoxyethylene-polyoxypropylene block copolymers and container contaning it) Download PDF

Info

Publication number
KR950703345A
KR950703345A KR1019950701458A KR19950701458A KR950703345A KR 950703345 A KR950703345 A KR 950703345A KR 1019950701458 A KR1019950701458 A KR 1019950701458A KR 19950701458 A KR19950701458 A KR 19950701458A KR 950703345 A KR950703345 A KR 950703345A
Authority
KR
South Korea
Prior art keywords
container
solution
daltons
molecular weight
less
Prior art date
Application number
KR1019950701458A
Other languages
English (en)
Korean (ko)
Inventor
매리 소우
크레이그 윌리암 데이비스
앨리슨 그린 플로이드
Original Assignee
엘. 디. 젠킨스
더 웰컴 파운데이션 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘. 디. 젠킨스, 더 웰컴 파운데이션 리미티드 filed Critical 엘. 디. 젠킨스
Publication of KR950703345A publication Critical patent/KR950703345A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019950701458A 1992-10-19 1993-10-18 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체가 주성분인 조성물 및 그것을 함유하는 컨테이너(composition based on polyoxyethylene-polyoxypropylene block copolymers and container contaning it) KR950703345A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9221883.3 1992-10-19
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation
PCT/GB1993/002141 WO1994008596A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it

Publications (1)

Publication Number Publication Date
KR950703345A true KR950703345A (ko) 1995-09-20

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701458A KR950703345A (ko) 1992-10-19 1993-10-18 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체가 주성분인 조성물 및 그것을 함유하는 컨테이너(composition based on polyoxyethylene-polyoxypropylene block copolymers and container contaning it)

Country Status (19)

Country Link
EP (1) EP0671919A1 (no)
JP (1) JPH08502284A (no)
KR (1) KR950703345A (no)
AU (1) AU674895B2 (no)
BR (1) BR9307268A (no)
CA (1) CA2147889A1 (no)
CZ (1) CZ63395A3 (no)
GB (1) GB9221883D0 (no)
HU (1) HUT75701A (no)
IL (1) IL107313A0 (no)
MX (1) MX9306467A (no)
NO (1) NO951462L (no)
NZ (1) NZ256890A (no)
PL (1) PL308459A1 (no)
SI (1) SI9300545A (no)
SK (1) SK44795A3 (no)
TW (1) TW276183B (no)
WO (1) WO1994008596A1 (no)
ZA (1) ZA937714B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185162A4 (en) * 2007-08-10 2012-04-25 Synthrx Inc POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES
CA2927361A1 (en) 2013-10-16 2015-04-23 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
EP3747448A1 (en) 2014-07-07 2020-12-09 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
IL107313A0 (en) 1994-01-25
TW276183B (no) 1996-05-21
SK44795A3 (en) 1996-05-08
CA2147889A1 (en) 1994-04-28
CZ63395A3 (en) 1995-07-12
HUT75701A (en) 1997-05-28
NZ256890A (en) 1995-10-26
WO1994008596A1 (en) 1994-04-28
EP0671919A1 (en) 1995-09-20
PL308459A1 (en) 1995-07-24
MX9306467A (es) 1994-05-31
NO951462L (no) 1995-06-13
HU9501104D0 (en) 1995-06-28
ZA937714B (en) 1995-04-18
GB9221883D0 (en) 1992-12-02
AU5284293A (en) 1994-05-09
JPH08502284A (ja) 1996-03-12
NO951462D0 (no) 1995-04-18
BR9307268A (pt) 1999-05-11
SI9300545A (en) 1994-06-30
AU674895B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
KR100212346B1 (ko) 인터페론 용액
US4647454A (en) Stable interferon β composition and a method of stabilizing interferon β
LU92237I2 (fr) Pegloticase et toute forme thérapeutique équivalente protégée par le brevet de base
FR2369290A1 (fr) Adsorbant pour proteine
ATE186838T1 (de) Keimtötende detergenz-jod-zusammensetzungen mit reduziertem detergenzgehalt
LV12657B (lv) Rapamicina kompozicija intravenozai (i/v) ievadisanai
KR940001879A (ko) 허용 가능한 맛을 가진 실질적으로 비자극 구강 조성물
KR970074791A (ko) 인터페론 결합체
KR890007754A (ko) 항체류의 안정화
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
KR950703345A (ko) 폴리옥시에틸렌-폴리옥시프로필렌 블록 공중합체가 주성분인 조성물 및 그것을 함유하는 컨테이너(composition based on polyoxyethylene-polyoxypropylene block copolymers and container contaning it)
DE60034445D1 (de) Gefriergetrocknete hgf-präparationen
DE69127886D1 (de) Copolymere auf Basis von N-Alkylacrylamid, deren Herstellung und deren Verwendung als Verdickungsmittel in Shampoozusammensetzungen
EA199600024A2 (ru) Жидкая стабильная фармацевтическая композиция, содержащая уратоксидазу и лиофилизат для ее получения
HK1012230A1 (en) Rapamycin formulations for iv injection
KR930019203A (ko) 메지스트롤 아세테이트 제제
KR890701736A (ko) 과산화물 분자변위보효소의 포합체
KR890001571A (ko) 독소루비신 히드로클로라이드 수용액
KR950005325A (ko) 제약 조성물
KR890000009A (ko) 농업용 생리활성제
KR910005886A (ko) 안정화 백혈구 인터페론
CA2396722A1 (en) Formulations of active components in the form of a solid dispersion
RU95109876A (ru) Упаковка фармацевтического назначения
KR910002443A (ko) 연질 캡슐용 폴리프레닐계 화합물 조성물
ES2076716T3 (es) Conjunto de carretilla elevadora.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid